{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043213","form_type":"8-K","ticker":"INVU","cik":"0000862651","company_name":"Investview, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.172118+00:00","generated_at":"2026-05-30T07:51:31.573076+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Investview acquires Renu Labs and repurchases 121M shares (6.5% of outstanding)","bullets":["Acquired Renu Laboratories, a manufacturer of proprietary health/beauty/wellness products; terms not disclosed.","Expects acquisition to be revenue accretive as early as Q4 2024 - Q1 2025 via iGenius cross-selling.","Repurchased 121M shares (6.5% of outstanding) from three non-affiliate shareholders at a discount to closing price.","Repurchase resolves a dispute related to 2017 issuance; price payable in 10 equal quarterly installments.","Plans to operate Renu under new myLife Wellness business unit leveraging its FDA-registered, cGMP facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043213","json":"https://secwatch.observer/filing/0001493152-24-043213.json","markdown":"https://secwatch.observer/filing/0001493152-24-043213.md","text":"https://secwatch.observer/filing/0001493152-24-043213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862651/000149315224043213/0001493152-24-043213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862651/000149315224043213/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:51:31.573076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}